EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Toward industrial microalgae-based monoclonal antibody production

Maximilian M Garwood, Ian L Ross, Ben Hankamer

Trends in Biotechnology · 2026-11

DOI: 10.1016/j.tibtech.2026.10.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Biotechnology, 2026-11. Verfasst von Maximilian M Garwood und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past two decades, Chinese hamster ovary cells have dominated monoclonal antibody (mAb) production. Although this mammalian cell system carries high operational and capital costs, it aligns well with regulatory requirements for producing high-value, modest-scale therapeutics. However, microalgal systems offer the benefits of light-driven growth, low-cost media, and the potential for significant and efficient scalability, providing a promising route for producing lower-cost mAbs. Reducted production costs and increased scale open novel market opportunities well beyond the therapeutic space. Here, we investigate the history of mAb production in microalgae, the recent molecular and bioprocessing advances that are likely to contribute to their industrial production, and the novel applications that could arise given access to lower-cost mAbs.

Schlagwörter

Stichwörter der Autor:innen

industrial biotechnologymicroalgaemolecular pharmingmonoclonal antibodiesrecombinant proteins

Autor:innen und Institutionen

  • Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.
  • Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia. Electronic address: b.hankamer@imb.edu.au.

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Garwood, M. M., Ross, I. L., & Hankamer, B. (2026). Toward industrial microalgae-based monoclonal antibody production. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2026.10.003

Vancouver

Garwood MM, Ross IL, Hankamer B. Toward industrial microalgae-based monoclonal antibody production. Trends in Biotechnology. 2026. doi:10.1016/j.tibtech.2026.10.003

BibTeX
@article{Garwood2026,
  author = {Garwood, Maximilian M and Ross, Ian L and Hankamer, Ben},
  title = {Toward industrial microalgae-based monoclonal antibody production},
  journal = {Trends in Biotechnology},
  year = {2026},
  doi = {10.1016/j.tibtech.2026.10.003}
}
Kostenlos starten →